Back to News
Feb 24, 2026 4:30 PM

AbCellera Biologics Q4 Earnings Report: What Investors Need to Know

The Q4 earnings report for AbCellera Biologics (NASDAQ:ABCL) was released on Tuesday, February 24, 2026 at 04:05 PM.

Here's what investors need to know about the latest announcement.

Earnings

AbCellera Biologics beat estimated earnings by 83.33%, reporting an EPS of $-0.03 versus an estimate of $-0.18.

Revenue was up $39.80 million from the same period last year.

Earnings History Overview

The company missed ...